SCHEMBL23312951

SCHEMBL23312951

CC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CN

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 0.61
▸ CYP3A4 P08684 3/20 0.49
▸ SLC7A5 Q01650 1/20 0.49
▸ SLC6A5 Q9Y345 1/20 0.48
▸ CA1 P00915 2/20 0.48
▸ CA2 P00918 2/20 0.48
▸ ITGB2 P05107 2/20 0.48
▸ ICAM1 P05362 2/20 0.48
▸ ITGAL P20701 2/20 0.48
▸ REN P00797 1/20 0.47
▸ HRH4 Q9H3N8 3/20 0.46
▸ HRH3 Q9Y5N1 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ THPO P40225 1/20 0.46
▸ CPB2 Q96IY4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16364168 0.89 CYP3A4 (0.54) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL2197786 0.87 SLC15A2 (0.72) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL30081493 0.87 SLC15A2 (0.72) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL15080457 0.85 REN (0.54) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL16656663 0.85 ITGB2 (0.50) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL17697368 0.82 CYP3A4 (0.54) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL16628203 0.82 SLC15A2 (0.63) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL29351097 0.82 SLC15A2 (0.69) SLC15A2CYP3A4SLC7A5SLC6A5CA1
SCHEMBL13187470 0.82 ITGB2 (0.49) CYP3A4SLC7A5SLC6A5CA1CA2
SCHEMBL27624890 0.81 SLC15A2 (0.61) SLC15A2REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10993983-B2 Cyclic peptide epitopes and small-molecule mimics for inducing autophagy TRUSTEES OF TUFTS COLLEGE (US) 2021-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10993983-B2 Cyclic peptide epitopes and small-molecule mimics for inducing autophagy BECN1, SQSTM1, ATG7 SLC15A2 928/4885CYP3A4 4769/4885SLC7A5 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback